Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2025 Earnings Call Transcript November 27, 2024 4:00 PM ET
Company Participants
Marcus Driller – VP, Corporate
Lewis Gradon – MD and CEO
Lyndal York – CFO
Conference Call Participants
Lyanne Harrison – BofA
Craig Wong-Pan – RBC
Daniel Hurren – MST Marquee
Adrian Allbon – Jarden
Vanessa Thomson – Jefferies
Matt Montgomerie – Forsyth Barr
Mathieu Chevrier – Citi
Andrew Paine – CLSA
Saul Hadassin – Barrenjoey
Marcus Curley – UBS
David Low – JPMorgan
Rob Morrison – Craigs
Operator
Welcome to Fisher & Paykel Healthcare’s Results Conference Call. My name is Taryn and I’ll be your operator for today’s call. At this time, everyone except the guest speakers will be in listen-only mode. Later, we’ll conduct a question-and-answer session. [Operator Instructions] Please note this conference call is being recorded. I would now like to turn the call over to Marcus Driller, VP, Corporate.
Marcus Driller
Thank you, Taryn. Good morning everyone and welcome to the conference call for Fisher & Paykel Healthcare’s first half results for the 2025 financial year. On the call today are Lewis Gradon, our Managing Director and Chief Executive Officer; Lyndal York, Chief Financial Officer; and Andrew Somervell, our VP of Products and Technology. Lewis and Lyndal will first provide an overview of the results and then we’ll move on to questions. We’ll be discussing our results for the six months ended 30 September, 2024. Earlier today we provided our 2025 interim report including financial statements and commentary on our results to the NZX and ASX. These disclosures can be accessed on our website at fphcare.com/investor.
With that, I’d now like to turn the call over to Lewis.
Lewis Gradon
Okay, thanks, Marcus and good morning to everyone. I’m going to be referring to the investor presentation pack that
